FDA clearance for P-Cure now includes full-body indications and supine treatment positions, significantly expanding clinical versatility and patient access SHILAT, Israel, May 15, 2025 /PRNewswire-PRWeb/ — P-Cure, a leader in compact proton therapy solutions, proudly announces that the U….
P-Cure Announces FDA Clearance Expansion for Full-Body and Supine Proton Therapy Treatments
This post was originally published on this site